MedTrace Logo

Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia

NCT06276816 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-02-26

No results posted yet for this study

Summary

This is a prospective clinical observation and registration study. The investigator aimed to evaluate the efficacy and safety of cardiac denervation ablation as a treatment strategy for severe sinus bradycardia.

Conditions

  • Sinus Bradycardia

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • yan Yao, PhD · Fuwai Hospital, National Center for Cardiovascular Diseases

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-13
Primary Completion
2024-09-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06276816 on ClinicalTrials.gov